Dataset Information

MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

ABSTRACT: MN1 encodes a transcriptional co-regulator without homology to other proteins, previously implicated in acute myeloid leukaemia and development of the palate. Large deletions encompassing MN1 have been reported in individuals with variable neurodevelopmental anomalies and non-specific facial features. We identified a cluster of de novo truncating mutations in MN1 in a cohort of 23 individuals with strikingly similar dysmorphic facial features, especially midface hypoplasia, and intellectual disability with severe expressive language delay. Imaging revealed an atypical form of rhombencephalosynapsis, a distinctive brain malformation characterized by partial or complete loss of the cerebellar vermis with fusion of the cerebellar hemispheres, in 8/10 individuals. Rhombencephalosynapsis has no previously known definitive genetic or environmental causes. Other frequent features included perisylvian polymicrogyria, abnormal posterior clinoid processes and persistent trigeminal artery. MN1 is encoded by only two exons. All mutations, including the recurrent variant p.Arg1295* observed in 8/21 probands, fall in the terminal exon or the extreme 3' region of exon 1, and are therefore predicted to result in escape from nonsense-mediated mRNA decay. This was confirmed in fibroblasts from three individuals. We propose that the condition described here, MN1 C-terminal truncation (MCTT) syndrome, is not due to MN1 haploinsufficiency but rather is the result of dominantly acting C-terminally truncated MN1 protein. Our data show that MN1 plays a critical role in human craniofacial and brain development, and opens the door to understanding the biological mechanisms underlying rhombencephalosynapsis.

SUBMITTER: Mak CCY

PROVIDER: S-EPMC7962909 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

Mak Christopher C Y CCY Doherty Dan D Lin Angela E AE Vegas Nancy N Cho Megan T MT Viot Géraldine G Dimartino Clémantine C Weisfeld-Adams James D JD Lessel Davor D Joss Shelagh S Li Chumei C Gonzaga-Jauregui Claudia C Zarate Yuri A YA Ehmke Nadja N Horn Denise D Troyer Caitlin C Kant Sarina G SG Lee Youngha Y Ishak Gisele E GE Leung Gordon G Barone Pritchard Amanda A Yang Sandra S Bend Eric G EG Filippini Francesca F Roadhouse Chelsea C Lebrun Nicolas N Mehaffey Michele G MG Martin Pierre-Marie PM Apple Benjamin B Millan Francisca F Puk Oliver O Hoffer Mariette J V MJV Henderson Lindsay B LB McGowan Ruth R Wentzensen Ingrid M IM Pei Steven S Zahir Farah R FR Yu Mullin M Gibson William T WT Seman Ann A Steeves Marcie M Murrell Jill R JR Luettgen Sabine S Francisco Elizabeth E Strom Tim M TM Amlie-Wolf Louise L Kaindl Angela M AM Wilson William G WG Halbach Sara S Basel-Salmon Lina L Lev-El Noa N Denecke Jonas J Vissers Lisenka E L M LELM Radtke Kelly K Chelly Jamel J Zackai Elaine E Friedman Jan M JM Bamshad Michael J MJ Nickerson Deborah A DA Reid Russell R RR Devriendt Koenraad K Chae Jong-Hee JH Stolerman Elliot E McDougall Carey C Powis Zöe Z Bienvenu Thierry T Tan Tiong Y TY Orenstein Naama N Dobyns William B WB Shieh Joseph T JT Choi Murim M Waggoner Darrel D Gripp Karen W KW Parker Michael J MJ Stoler Joan J Lyonnet Stanislas S Cormier-Daire Valérie V Viskochil David D Hoffman Trevor L TL Amiel Jeanne J Chung Brian H Y BHY Gordon Christopher T CT

Brain : a journal of neurology 20200101 1

MN1 encodes a transcriptional co-regulator without homology to other proteins, previously implicated in acute myeloid leukaemia and development of the palate. Large deletions encompassing MN1 have been reported in individuals with variable neurodevelopmental anomalies and non-specific facial features. We identified a cluster of de novo truncating mutations in MN1 in a cohort of 23 individuals with strikingly similar dysmorphic facial features, especially midface hypoplasia, and intellectual disa ...[more]

PMID: 31834374

Similar Datasets

Project description:The Hedgehog receptor, Patched1 (PTCH1), is a well-known tumour suppressor. While the tumour suppressor's activity is mostly ascribed to its function as a repressor of the canonical Smoothened/Gli pathway, its C-terminal domain (CTD) was reported to have additional non-canonical functions. One of them is the reduction of autophagic flux through direct interaction with the Unc-51, like the autophagy activating kinase (ULK) complex subunit autophagy-related protein-101 (ATG101). With the aim of investigating whether this function of PTCH1 is important in cancer cell fitness, we first identified frameshift mutations in the CTD of PTCH1 in cancer databases. We demonstrated that those mutations disrupt PTCH1 interaction with ATG101 and increase autophagic flux. Using deletion mutants of the PTCH1 CTD in co-immunoprecipitation studies, we established that the 1309-1447 region is necessary and sufficient for interaction with ATG101. We next showed that the three most common PTCH1 CTD mutations in endometrial, stomach and colon adenocarcinomas that cause frameshifts at S1203, R1308 and Y1316 lack the ability to interact with ATG101 and limit autophagic flux, determined by bafilomycin A1-sensitive accumulation of the autophagy markers LC3BII and p62. We next engineered PTCH1 indel mutations at S1223 by CRISPR/Cas9 in SW620 colon cancer cells. Comparison of two independent clones harbouring PTCH1 S1223fs mutations to their isogenic parental cell lines expressing wild-type PTCH1 showed a significant increase in basal and rapamycin-stimulated autophagic flux, as predicted by loss of ATG101 interaction. Furthermore, the PTCH1 CTD mutant cells displayed increased proliferation in the presence of rapamycin and reduced sensitivity to glycolysis inhibitors. Our findings suggest that loss of the PTCH1-ATG101 interaction by mutations in the CTD of PTCH1 in cancer might confer a selective advantage by stimulating autophagy and facilitating adaptation to nutrient deprivation conditions.

Dataset Information

MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

Publications

MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets